Angiogenesis during reactive and pathologic processes is characteristically associated with inflammation. Inflammatory cells participate in angiogenesis by secreting different molecules that affect endothelial cell functions. We had previously shown that induced tissue factor (TF) expression in activated microvascular endothelial cells (mEC) is able to induce angiogenesis via autocrine regulation. However, the signals that induce TF expression in mEC are not fully known. Here, we demonstrate that monocyte paracrine cross-talk with mECs triggers mEC-TF expression. We have identified that monocyte-secreted Wnt5a induces TF expression in mEC and functionally induces cell monolayer repair and angiotube formation in vitro as well as microvessel formation in vivo. Monocyte-secreted Wnt5a activates FZD5 in mECs, which signals to induce the release of intracellular Ca 21 and increase NFkB transcription activity and TF gene expression. In sum, Wnt5a secreted by monocytes signals through the noncanonical Wnt-FZD5 pathway in mECs to induce TF expression that induces angiogenesis by autocrine regulation.
Introduction
Angiogenesis is a complex process defined as the new blood vessel formation from pre-existing ones. Such biological processes occur in either physiological or pathological conditions (Folkman, 1995) . The angiogenic process plays an essential role in embryo development, organogenesis, and tissue growth. In adults, this process is quite limited due to the fact that blood vessels remain quiescent; however, they can be activated after stimuli, such as hypoxia, wound healing, or diverse pathological situations as in tumorogenesis and atherosclerosis.
During angiogenesis, microvascular endothelial cells (mECs) are exposed to several pro-and anti-angiogenic factors that interact and eventually degrade the basal membrane, pervade bordering tissue, and expand themselves until forming tube-like structures. As a final step, pericytes and vascular smooth muscle cells are recruited to form mature new microvessels. Within the molecular mechanisms that control angiogenesis, we recently have reported that endogenous tissue factor (TF) expression in mECs regulates the formation and stabilization of microvessels (Arderiu et al., 2011) .
TF is a 47 kDa transmembrane glycoprotein considered to be the essential initiator of blood coagulation. TF is a cofactor of FVIIa and an agonist of the protease-activated receptor 2 (PAR2). In addition to its roles in the coagulation cascade, TF seems to have a multifactorial role in atherogenesis inflammation, angiogenesis, and metastasis (Carmeliet et al., 1996) . TF expression within the vasculature is strictly regulated and normally not observed under physiological conditions in endothelial cells (ECs) (Drake et al., 1989) . In response to various pathological stimuli, TF expression and activity can be induced in ECs and most of these stimuli share similar signal transduction pathways to induce procoagulant activity. However, the signals that induce TF-mediated angiogenesis in mECs are poorly understood.
Angiogenesis is critically involved in the response of the organism to ischemic injury, and contributes to revascularization and organ preservation (Carmeliet, 2003) . Infiltration of inflammatory cells in hypoxic areas is a hallmark to tissue ischemia (Silvestre et al., 2008) . Monocytes have been shown to promote angiogenesis by releasing angiogenic growth factors, cytokines, and metalloproteinases (Czepluch et al., 2014; Jaipersad et al., 2014) . Interaction between monocytes and ECs results in crossmodulation of several biological functions. Migrated cell surface is represented in percent of control at 10 h. Values are expressed as mean + SE (*P , 0.05 vs. control media). (B) TF mRNA levels at 2 h were obtained by qRT-PCR. Results of relative mRNA expression from three different experiments are expressed as mean + SE (**P , 0.005 vs. control). (C) TF and b-actin protein levels in HMEC-1 cultured with MCM for 10 h were determined by immunoblotting. Blots are representatives from three independent experiments. Quantitative results of TF levels normalized to b-actin are expressed as mean + SE (*P , 0.05 vs. control). (D) Phase-contrast micrographs show tube-like structures of HMEC-1 cultured on 3DBM with MCM for 24 h. Completed medium supplemented with TNFa (100 ng/ml) was used as positive control. Tube-like structures were analyzed by measuring quantity of Contact of monocytes with ECs accelerates endothelial dysfunction and increases TF-dependent procoagulant activity (PCA) (Napoleone et al., 1997) . Whether inflammatory cells are also able to trigger other TF-dependent functions is not known.
Previously, we have reported the pro-angiogenic effects of TF intracrine signaling in mECs (Arderiu et al., 2011) , but the inducers/triggers of mECs activation and TF-induced expression were not known. In this study, we hypothesized that released proteins from monocytes could be potential triggers of mEC activation and induce mEC-TF expression. Because angiogenesis involves migration and proliferation, we considered the possible involvement of the Wnt pathway that regulates fundamental aspects of tissue morphogenesis and vascular development (Logan and Nusse, 2004) . Moreover, macrophages are known to regulate developmental and wound angiogenesis via noncanonical Wnt-Flt1 signaling (Stefater et al., 2011 (Stefater et al., , 2013 . Wnts constitute a large family of cysteine-rich secreted ligands, which trigger cellular responses through various pathways, referred to as canonical or noncanonical, using the Frizzled family of receptors (Slusarski et al., 1997; Logan and Nusse, 2004; Blumenthal et al., 2006) .
Here, we show for the first time that mEC are induced to trigger intracrine TF signaling and angiogenesis by interacting with monocytes via Wnt5a-FZD5.
Results

The secretome of monocytes induces endothelial cell migration and upregulates TF gene expression
The secretome of isolated serum-free cultured human monocytes was isolated and added to wounded mEC monolayers to test migration and repair. Monocyte purity was detected by flow cytometry. Ten hours after wounding, mECs incubated with the secretome of monocytes (MCM) had mostly repaired the woundexposed surface ( Figure 1A) . Moreover, TF gene expression was upregulated in mECs treated with MCM (2 h) ( Figure 1B ) and TF protein expression at 10 h (time point of wound closure) was also upregulated ( Figure 1C ). In addition, human umbilical vein endothelial cells (HUVEC) responded similarly to MCM (Supplementary Figure S1) . In order to show that the increased migration was TF dependent, wound healing assay was performed in confluent TF-silenced mECs. Results show that TF-silenced cells were not able to migrate; however, when TF-silenced cells were cultured in MCM, which restored TF mRNA and protein expression, cells migrated at the same level of scrambled siRNA cells cultured in control media (Supplementary Figure S2A, C and D) . It is clear that 14 h after wound healing, TF-silenced cells did not migrate but the presence of MCM-induced wound closure (Supplementary Figure S2B) . All together, these results show that TF expression induced by monocyte released is sufficient to promote migration.
The secretome of monocytes induces endothelial angiotube formation and TF gene expression mECs were cultured in matrigel with and without MCM, and tube-like formation was evaluated by measuring nodules, tube length, and covered area at 24 h. Tumor necrosis factor a (TNFa) (100 ng/ml), a cytokine known to induce TF (Kirchhofer et al., 1994) , was used as a positive control. Results showed a significant induction of angiogenesis by MCM and TNFa ( Figure 1D ). In addition, a highly significant induction of TF gene expression (at 2 h) and TF protein expression (at 4 h sustained until 24 h) was observed ( Figure 1E and F) . Interestingly, the effects of MCM were similar in HUVECs (Supplementary Figure S1) . Because TNFa has been described to induce TF expression in endothelial cells, we discriminated whether the effects observed in TF expression were due to TNFa secreted by monocytes, by adding anti-TNFa antibody to MCM (Supplementary Figure S3) . The presence of the anti-TNFa blocking antibody neither modified TF expression nor blocked tube formation. These results indicate that a soluble mediator(s) released by monocytes in their secretome, other than TNFa, induce(s) endothelial TF expression, cell migration, and angiotube formation.
Monocyte-derived Wnt5a upregulates endothelial TF expression
Because exogenous Wnt5a added to endothelial cell cultures had been shown to enhance endothelial cell survival and proliferation (Masckauchan et al., 2006) , and Wnt5a could be induced by microbial induction in human mononuclear cells (Blumenthal et al., 2006) , we tested whether Wnt5a could be secreted by monocytes and stimulate mECs-TF expression. Figure 2A shows that monocytes contain and release Wnt5a. In addition, Wnt5a protein levels were increased in mECs cultured for 4 h with MCM ( Figure 2B and C). However, Wnt5a mRNA levels were not modified in mECs, indicating that mECs recruit Wnt5a from MCM. To investigate whether Wnt5a secreted by monocytes regulates microvascular tube formation, mECs were cultured in matrigel with MCM from scrambled or Wnt5a-silenced monocytes. Reductions of 70% + 5% for mRNA and 50% + 6% for protein levels of Wnt5a were evidenced in monocytes transfected with Wnt5a siRNA (Supplementary Figure S4) . Tube-like formation was evaluated by measuring nodules, tube length, and covered area at 24 h. Figure 3A shows a significant decrease in nodules, tube length, and covered surface when mECs were cultured for 24 h in the presence of MCM obtained from Wnt5a-silenced monocytes. A reduction in capillary tube-like formation was accompanied by a reduction in TF mRNA and protein expression ( Figure 3B ).
In addition, to confirm that Wnt5a was directly involved in upregulating TF expression and in angiotube formation, recombinant human Wnt5a (R&D Systems) was added to mEC in threedimensional basement membrane (3DBM) cultures. Angiogenesis was tested by measuring nodules, tube length, and % of covered surface. Figure 4A shows a significant increase in nodules, tube length, and covered surface when mECs were cultured for 24 h in the presence of Wnt5a protein, showing dose-response effect. Interestingly, TF mRNA and TF protein levels (measured at 2 and 24 h, respectively) were also upregulated by Wnt5a in the same manner ( Figure 4B and C) .
To directly analyze the role of Wnt5a in the increased TF expression in mECs, TF-promoter transfected mECs were treated with Wnt5a protein during 24 h at different doses (0, 75, and 200 ng/ml final concentration). A significant enhanced activity of the TF promoter activity was observed at 75 and 200 ng/ml of Wnt5a ( Figure 4D ).
To further understand the role of Wnt5a on TF expression during angiotube formation, we examined whether in TF-silenced cells addition of exogenous Wnt5a protein would restore angiotube formation. Specific TF silencing in mECs cells significantly reduced tube formation, TF mRNA and TF protein expression levels, as previously seen (Arderiu et al., 2011) . Addition of Wnt5a protein reversed the inhibitory effect of TF silencing ( Figure 4A) , and restored TF mRNA and TF protein expression ( Figure 4E and F) .
These results together indicate that monocytes release Wnt5a and activate mECs to produce TF and that Wnt5a is upstream of TF and regulates its expression and function in angiogenesis.
Wnt5a signaling in endothelial cell promotes TF expression
Wnt5a induces signal transduction in target cells by binding to their receptors, the Frizzled family, a cysteine-rich seven transmembrane receptor family. We studied whether Wnt5a secreted by monocytes binds to FZD5 in mECs and induces signaling and TF expression. Figure 5 shows that MCM from monocytes increased FZD5-mRNA and FZD5-protein levels in mECs. When Wnt5a was silenced in monocytes and consequently it was not present in MCM, FZD5 was not significantly modified ( Figure 5A and B). In order to show that monocyte-secreted Wnt5a signals through FZD5 and induces TF expression in mECs, FZD5 was silenced. Results showed that MCM was not able to induce TF expression in FZD5-silenced mECs (Supplementary Figure S5A) . Same results were obtained when Wnt5a was added to the culture of FZD5-silenced mECs. Results indicated that FZD5 is required to induce Wnt5a response in mECs.
These results indicated that Wnt5a signals through FZD5, a noncanonical pathway, in mECs. Noncanonical Wnt pathway activation can involve the release of Ca 2+ from intracellular stores and we observed that Wnt5a addition to mECs increased intracellular Ca 2+ ( Figure 5C ). Furthermore, increases in Ca 2+ may activate S-methionine/cysteine hydrolysate Escherichia coli for 16 h, then the MCM was collected and added to HMEC-1 for 4 h. Cells (monocytes, mECs) were lysed with RIPA buffer and immunoprecipitated with anti-Wnt5a antibody. IP samples were run in SDS -PAGE and detected by Phosphorimager. Column 1 shows Wnt5a in monocytes; Column 2 shows Wnt5a in MCM; Column 3 shows Wnt5a recruited by mECs; Column transcription factors as the nuclear factor-kappa B (NFkB) (Mill and George, 2012) , which has a recognition site on the TF promoter (Mackman et al., 1991) . Our results show that NFkB is increased in mECs when cultured with MCM and is not modified when cultured with MCM from Wnt5a-silenced monocytes ( Figure 5A and B). To confirm that Wnt5a induces TF expression in mECs through the noncanonical pathway, Wnt5a recombinant protein was added to mECs cultured in 3DBM. The addition of Wnt5a protein increased FZD5 and NFkB mRNA and protein expression ( Figure 5D and E). Moreover, Wnt5a not only induced NFkB expression, but also induced NFkB activation. We observed increased phospho-NFkB p65 and movement from the cytoplasm to the nucleus fraction, demonstrating an activation of NFkB (Supplementary Figure S6A and B). In addition, in mECs cultured with MCM from Wnt5a-silenced monocytes, total Figure 4 Effect of recombinant Wnt5a on TF expression during angiogenesis. Recombinant human Wnt5a protein was added to scrambled siRNA HMEC-1 (siC) cultures at different concentrations (25, 50, 75, and 200 ng/ml) or into TF-silenced HMEC-1 (siTF) cultures at 200 ng/ml. Cells were seeded and cultured on a 3DBM system. (A) Phase-contrast micrographs show tube-like formation at 24 h. Tube-like structures were analyzed by measuring quantity of nodules, tube length, and % of covered surface of tubes. Data from three independent experiments are expressed as mean + SE (*P , 0.05, **P , 0.005 vs. siC with 0 ng/ml Wnt5a and # P , 0.05, ## P , 0.005 vs. the correspondent siRNA). (B) TF mRNA levels at 2 h were determined by qRT-PCR. Results of relative mRNA expression are expressed as mean + SE (**P , 0.005 vs. 0 ng/ml Wnt5a). (C) TF and b-actin protein levels were measured by immunoblotting. Blots are representatives from three independent experiments. Results of relative TF protein expression normalized to b-actin are expressed as mean + SE (*P , 0.05 vs. 0 ng/ml Wnt5a). (D) TF promoter activity in HMEC-1 cultured with 0, 75, or 200 ng/ml Wnt5a for 24 h. RLU data from three independent experiments are expressed as mean + SD (*P , 0.005 vs. 0 ng/ml Wnt5a). TF-silenced HMEC-1 (siTF) cells were cultured in the presence or absence of human recombinant Wnt5a. TF and Wnt5a mRNA levels at 2 h (E) and protein levels of TF, Wnt5a, and b-actin at 24 h (F) were measured. Results of relative mRNA or protein level are expressed as mean + SE (**P , 0.005 vs. siC and expression of NFkB p65 was reduced as well as its localization in the nucleus fraction (Supplementary Figure S6C and D) . In addition, to demonstrate the direct relation between Wnt5a-NFkB and TF, NFkB p65 was silenced in mECs. Supplementary Figure S3F shows that inhibition of NFkB decreased TF expression and it was not rescued by addition of Wnt5a protein.
To further test the pathway, we silenced TF in mECs and added Wnt5a to the cultures. Levels of FZD5 and NFkB mRNA and protein were unaffected by TF silencing but were increased when recombinant Wnt5a was added ( Figure 5D and E).
Wnt5a has also been reported to activate the canonical pathway (Mikels and Nusse, 2006) . To exclude that Wnt5a secreted by monocytes was not signaling by the canonical pathway in mECs, TF expression was analyzed in LRP5-silenced mECs cultured in MCM. Inhibition of LRP5 did not modify TF expression (Supplementary Figure S5B) .
All together, these results indicated that Wnt5a secreted by monocytes interacts with its receptor FZD5 in mECs and through the noncanonical Wnt pathway release intracellular calcium that induces NFkB translocation to the nucleus and TF gene transcription. TF expression in mEC is then able to signal (via autocrine regulation) (Arderiu et al., 2012a) and to start the migration program to form neovessels (Supplementary Figure S7) .
Wnt5a-TF induces microvessel formation in vivo
To evidence that the Wnt5a-TF axis induces microvessel formation in vivo, we performed two different experimental approaches. First, we subcutaneously inoculated nude mice with (i) PBS as control; (ii) mECs and scrambled siRNA monocytes (total number of cell 1 × 10 7 cells; ratio 1:1); (iii) mECs and Wnt5a siRNA monocytes (1 × 10 7 cells; ratio 1:1); and (iv) mECs and Wnt5a siRNA monocytes (1 × 10 7 cells; ratio 1:1) plus recombinant Wnt5a in matrigel plugs. The cells implanted in matrigel plugs retained their viability and silencing was sustained over the course of the entire experiment (data not shown). Angiogenesis was evaluated after 7 days. Plugs that contained only PBS (control) did not induce angiogenesis as indicated by the absence of the capillaries in the skin around the plug ( Figure 6A , upper image) or inside the plug ( Figure 6A , lower image). However, skin surrounding the implanted matrigel plug (with mECs and scrambled siRNA monocytes) showed welldeveloped zones of neovascularization ( Figure 6B , upper image), and we found abundant blood-filled channels containing red blood cell in the plug ( Figure 6B , lower image and F). In contrast, neovascularization was significantly suppressed in plugs implanted with mECs plus Wnt5a-silenced monocytes, as few branches were developed around the main vessel, and these microvessels were not stable showing leaking zones ( Figure 6C ). When Wnt5a recombinant protein was added in the plug, active angiogenesis with thick main vessels and many secondary branches were observed ( Figure 6D ). These microvessels were functional as demonstrated by the presence of red cells within the vessel ( Figure 6F ). The hemoglobin content normalized to the weight of the analyzed fragment of matrigel was significantly lower in matrigel plugs, containing mECs plus Wnt5a siRNA monocytes. Microvessel formation and hemoglobin contents were rescued by addition of Wnt5a recombinant protein.
In the second approach, we demonstrated the direct effect of Wnt5a in mECs. Nude mice were subcutaneously inoculated with (i) PBS; (ii) 5 × 10 6 scrambled siRNA mECs; (iii) TF siRNA cells; (iv) TF siRNA cells plus recombinant Wnt5a; (v) Wnt5a siRNA cells and (vi) Wnt5a siRNA cells plus recombinant TF in matrigel plugs. Angiogenesis was evaluated as described above. As before, plugs that contained only PBS (control) did not induce angiogenesis. Figure 7B shows that skin surrounding matrigel plug with scrambled cells (WT) contained sprouting endothelial microvessels and showed frequent branching and abundant blood-filled channels containing red blood cells. However, when TF was silenced few single small un-branched vessels were observed and we did not find any stable structure inside the plug ( Figure 7C ). Recombinant Wnt5a added to TF-silenced endothelial cells was able to recover microvessel formation, and a thick mesh of microvessels surrounded by branching structure of microvessels was formed and all of them contained red blood cells ( Figure 7D) . Moreover, when we inoculated Wnt5a-silenced mECs, short vessels without branching were found (Supplementary Figure  S8) , and addition of TF recombinant protein rescued vessel with long structure formation. Furthermore, our results show that monocytes increased angiogenesis and this effect was mediated by Wnt5a (Supplementary Figure S9) . All these results indicate that Wnt5a through TF signaling induces microvessel formation.
Angiogenesis in atherosclerotic lesions of human coronary arteries
Microvessels surrounded by macrophages were searched in human coronary atherosclerotic plaques. Previously we demonstrated that advanced human atherosclerotic coronary arteries have an extended network of microvessels (Arderiu et al., 2011) . Supplementary Figure S10A shows a human coronary artery atherosclerotic plaque with significant neovascularization (red for vWF staining) in the medial and intimal layers with infiltration of monocyte-macrophages (green) around microvessels. Moreover, as we previously showed, we find by double immunolocalization studies that TF expression is found in microvessels within atherosclerotic lesions colocalizing with microvascular endothelial cells but not in the luminal endothelial cells (Supplementary Figure  S10C) . In addition, we found zones with monocyte-macrophages (green) and high levels of Wnt5a (red) (Supplementary Figure  S10D) . Zones with high TF expression (red) are also positive for Wnt5a (green) (Supplementary Figure S10E) . Together these findings show a common tissue localization that is coincident with the concept proposed in this work of monocytes driving mECs activation through Wnt5a release, Wnt5a binding to mECs, and inducing TF expression that by intracrine regulation will induce microvessel formation. In addition, Supplementary Figure S11 shows immunostaining on explanted matrigel plugs. Localization of mECs (positive vWF, red) and monocytes (green) can be seen in neovessels, as well as localization of mECs (vWF/red) and TF (green). Finally, localization of TF (green) and FDZ5 (red) was also observed.
Discussion
Intracellular TF upregulation in mECs induces microvessel formation and its stabilization by attracting pericytes (Arderiu et al., 2011) . However, which kind of stimulus induces TF expression in mECs and promotes angiogenesis remains unknown. MonocytemEC interactions play a key role in the innate inflammatory response, thrombosis, and development of atherosclerotic lesions (Ross, 1993) . Adhesion of monocytes seems to upregulate TFdependent procoagulant activity in ECs (Napoleone et al., 1997; Sakamoto et al., 2005) . In this study, we demonstrate that monocytes secrete Wnt5a that binds to FZD5 in mECs and activates the Wnt5a noncanonical pathway inducing TF expression. TF by intracrine signaling triggers microvessel formation (Supplementary Figure S7) .
Monocytes have been directly implicated in the angiogenic process to improve tissue perfusion (being protective) or localizing inside atheroma plaque (being detrimental) (Ribatti et al., 2008) .
Monocytes participate in the angiogenic process by secreting pro-and anti-inflammatory cytokines, which could control mEC proliferation, their survival and apoptosis, as well as their migration and activation. Monocytes are a heterogeneous cell population, and it has recently been demonstrated that monocyte subsets partially differ in their contribution to angiogenesis (Czepluch et al., 2014) . However, the mechanism of induction of angiogenesis of the distinct human monocyte subsets is largely unknown so far. Using a standardized mEC migration wound repair assay, we identified that the secretome of cultured CD14 + monocytes induced monolayer wound repair, and our results also indicated that secreted molecules from siRNA scrambled monocytes were able to induce TF expression in mECs and consequently endothelial angiotube formation. Pro-inflammatory cytokines released by monocytes have been extensively studied in this context. TNFa secreted by monocytes was demonstrated to induce angiogenesis (Leibovich et al., 1987) as well as TF protein expression and TF procoagulant activity in endothelial cells (Bevilacqua et al., 1986; Kirchhofer et al., 1994; Napoleone et al., 1997) . However, blocking TNFa by a functional antibody in MCM did not affect angiotube formation; therefore, the signaling effects measured in this study were not TNFa-dependent. Here, we have identified Wnt5a as the protein secreted by monocytes that regulate TF in mECs. Further studies will be required to analyze the role of monocyte subsets in the pathway here identified.
In macrophages, one of the mechanisms that may regulate wound angiogenesis involves a noncanonical Wnt pathway by Flt1 signaling (Stefater et al., 2013) . Wnts are lipid-modified secreted glycoproteins that regulate diverse biological processes. Wnts trigger intracellular responses through various signaling pathways, referred to as canonical or noncanonical, using the Frizzled family receptors (Logan and Nusse, 2004) or in complex with co-receptors as Ror2. Wnt5a, which triggers the noncanonical Wnt pathway, induces cell proliferation and survival in primary endothelial cells (Masckauchan et al., 2006) . Noncanonical Wnt pathway activation involves Ca 2+ release, elevated levels of cytosolic Ca 2+ , and activation of the transcription NFkB that regulate a multitude of cellular functions including cytoskeletal organization, cell polarity, and cell motility (Mill and George, 2012) . The Ca 2+ pathway activated by Wnts promotes the formation of capillary-like networks of endothelial cells in vitro as well as endothelial cell proliferation and survival, suggesting a pro-angiogenic role in vivo (Cheng et al., 2008) . Moreover, it has been described that NFkB in the nucleus can bind the target sites in the TF gene promoter to regulate the induction of TF gene transcription (Parry and Mackman, 1995; Holschermann et al., 2001) . Thus, we have found that monocytes secrete Wnt5a, which binds FZD5 and through noncanonical Wnt pathway signaling promotes TF expression. FZD5 was shown to be essential for yolk and placental angiogenesis (Ishikawa et al., 2001 ) and TF deficiency in mice causes abnormalities of vascular pericytes, resulting in defective yolk sac vessel development and subsequent embryo wasting during embryogenesis (Carmeliet et al., 1996) . Here, we show that FZD5 and TF are related by the noncanonical Wnt signaling cascade in adult cells with clear functions.
Interaction of Wnt5a with FZD5 involved Ca 2+ release and finally NFkB activation that promoted TF gene upregulation. It has been shown that persistent NFkB-mediated signal transduction is closely linked to plaque progression, destabilization, and rupture (Brand et al., 1996) . Moreover, NFkB has also been related with upregulation of genes responsible for cell proliferation and cancer (Grivennikov and Karin, 2010) . Here we show how in mECs, NFkB activation induces TF expression and microvessel formation.
Plaque rupture is the principal cause of luminal thrombosis in acute coronary syndromes (Davies and Thomas, 1984) . In atherosclerotic plaque formation, the initial phase of intimal thickening is angiogenesis independent; however, when plaque enlarges it is believed that the ensuing hypoxia, inflammatory cell infiltration and high levels of internalized low-density lipoproteins (LDL), promote plaque neovascularization (Jain et al., 2007) . Plaque neovascularization may promote plaque rupture events by direct and indirect mechanisms. Intermittent hemorrhage from newly formed plaque capillaries traps blood cells and other proatherogenic molecules, which abruptly induce inflammation and trigger a period of plaque instability (Kolodgie et al., 2003; Virmani et al., 2005) . Vulnerable plaques are also characterized by increased levels of TF, mainly from infiltrated macrophages (Moons et al., 2002) . Although, there is a paucity of this type of samples, the information that we retrieve from them is very important and unique. However, immunohistochemistry in human coronary plaques is difficult because samples have to be processed without delay to probe the epitopes searched and this process is not easy with human material. Autopsy material was of no value and we looked for heart transplant samples. Nonetheless, as a proof of principle of our results we investigated human coronary plaques. In these coronary atherosclerotic plaques we have been able to localize monocytes, Wnt5a, and microvascular endothelial cells positive for TF forming neovessels in the same niche (Supplementary Figure S10) .
In sum, our results indicate that monocytes have an important role in promoting angiogenic processes by secreting Wnt5a and activating the noncanonical pathway in mECs. Wnt5a secreted by monocytes interacts with FZD5 as Wnt5a receptor, releases intracellular Ca 2+ , and finally induces NFkB activation and TF gene upregulation in mECs ( Figure 6 ). TF expression in endothelial cells is then able to signal and trigger neovessel formation by intracrine regulation.
Material and methods
Cell culture
Immortalized human microvascular endothelial cell line (HMEC-1) (Ades et al., 1992) , from the Center of Disease Control (Atlanta, GA, USA) was used. HMEC-1 were maintained in MDCB131 (Invitrogen) supplemented with 10% fetal bovine serum (FBS), 2 mM glutamine (Invitrogen) and 50 mg/ml gentamicin (Invitrogen). Key experiments were repeated using primary human umbilical vein endothelial cell (HUVEC), obtained from Advancell. HUVECs were cultured in MEM199 (Invitrogen) supplemented with 20 mM HEPES, pH 7.4 (Invitrogen), 20% FBS, 30 mg/ml of endothelial cell growth supplement (ECGS, Sigma-Aldrich) 1 mM pyruvate (Invitrogen), 2 mM glutamine (Invitrogen), 100 mg/ml heparin (Sigma) and antibiotics (100 U/ml penicillin and 0.1 mg/ml streptomycin; Invitrogen). HUVECs were used between passages 3 and 6.
Isolation of human peripheral blood monocytes
Peripheral blood mononuclear cells (PBMC) were isolated from human buffy coats of healthy donors by gradient centrifugation over Ficoll-Paque Plus (GE Healthcare). PBMC were subsequently collected and washed in PBS four times. Cell number and viability were determined using a Beckham-Coulter. PBMC were seeded in surface-modified polystyrene dishes for enhanced cell attachment (BD Falcon) and were cultured in RPMI 1640 (Gibco) supplemented with 10% of human serum A/B. After 4 -6 h, cultures were washed in PBS four times, removing non-attached cells, and fresh medium was added. Total attached monocytes were cultured for additional 18 h; then, the medium was collected. CD14 expression was detected by flow cytometry as a monocytes purity marker. Cells were removed from plates using PBS containing 0.53 mM EDTA and incubated with CD14-PerCP monoclonal antibody (Inmunostep, dilution 1:10). For each sample, at least 10000 events were acquired on a Coulter Epics XL Flow Cytometer equipped with a 488-nm argon laser (Beckman Coulter). Samples incubated with the same final concentration of isotype-matched antibody were used as a negative control. The data were analyzed with the Expo32 program (Beckman Coulter).
Wound repair assay
ECs were seeded on sterile culture dishes and grown on monolayer until confluence. The monolayer was scratched to form a double-sided scrape wound as previously described (Pena et al., 2012) . Wound repairs were assessed either with freshly monocytes medium or with supernatant of monocytes. Images were acquired at time 0, 2, 4, 6, 8, and 10 h under 10× objective. They were digitalized and processed with a Leica DMIRE2 microscope attached to a video SPOT Leica-DFC350FX camera. Wounds areas were analyzed by using ImageJ and StatView software.
Tube formation in vitro assay
Tube formation assay was performed as described (Arderiu et al., 2007) . Three-dimensional cultures were prepared by seeding ECs on basement membrane (3DBM) (BD Matrigel TM , BD Biosciences) coated plates. Cells were incubated for 24 h in the medium collected from monocyte culture supernatants, as we previously described. ECs grown in monocytes medium were used as negative control and ECs cultured in medium supplemented with 100 ng/ml of TNFa were used as positive control. In some experiments we added anti-TNFa blocking antibody in MCM (Abcam #ab6671). Experiments were performed in the presence of IgG control (Millipore, . Images were acquired at time 0, 4, and 24 h, digitalized and processed with Leica DMIRE2 microscope and SPOT Leica-DFC350FX camera. Tube length and surface covered with tubes were analyzed by using ImageJ. Nodules were also counted. Values were expressed as quantity of nodules, tube length, and the percentage of covered surface with tubes versus control samples.
Silencing RNA
Three-dimensional cultures were prepared as we previously described. The insertion of small interfering RNAs (siRNAs) into mECs and monocytes was done with a Nucleofector device and its corresponding kits (Amaxa, Inc.). Transfection protocols were performed following the manufacturer's instructions using the T16 or X01 programs. The siRNAs against TF (s4932), Wnt5a (s14873), FZD5 (s15416), and LRP5 (s8293) were purchased from Applied Biosystems and NFkB p65 (s6534) from Cell Signaling. In all experiments, a scrambled siRNA (Silencer Negative control siRNA from Applied Biosystems #AM4638) was used as control to evidence any unspecific changes to the gene expression profile or in cell phenotype that may result from the use of siRNA.
RNA and protein extraction from 3DBM cultures
Cells grown in matrigel were isolated and washed with cold PBS without Ca 2+ and Mg 2+ , containing 5 mM EDTA, as described in Arderiu et al. (2007) . Cells were then scraped into a centrifuge tube with 15 ml cold PBS/EDTA and incubated for 45 min on ice. Once matrigel was disassociated, the tubes were centrifuged and the pellet was resuspended in the appropriate volume of lysis buffer for RNA or protein isolation. Soluble and insoluble subcellular fractions were obtained as described (Arderiu et al., 2007) .
Real-time PCR
Total RNA from cultures was isolated by RNeasy isolation kit (Qiagen) according to the manufacturer's recommendations and reverse transcripted with High Capacity cDNA Archive Kit (Applied Biosystems) with random primers. Assays-on-Demand TM (applied Biosystems) of TaqMan TM fluorescent real-time PCR primer were used for TF (Hs00175225_m1), Wnt5a (Hs00180103_m1), FZD5 (Hs00258278_s1), NFkB (Hs00765730_m1), and GADPH (4326317E) (Applied Biosystems), which was used as endogenous control.
Protein extraction from monolayer cultures and western blot analysis
Protein was extracted from total cell lysates by using RIPA buffer (50 mM Tris-HCl pH 8, 150 mM NaCl, 1% NP-40, 0.5% sodium Deoxycholate, 0.1% SDS). Protein concentrations were measured with 2-D Quant Kit (GE Healthcare). Twenty-five micrograms of protein samples were separated by 10% SDS-PAGE gels. Then, they were transferred onto nitrocellulose membranes. After blocking for non-specific binding with 5% Albumin Bovine Fraction V (MP Biomedical), membranes were incubated with primary antibodies, including polyclonal anti-TF antibody (American Diagnostica, #4501, dilution 1:1000); monoclonal anti-Wnt5a antibody [3D10] (Abcam, #ab86720, dilution 1:500); polyclonal anti-Frizzled 5 antibody (Abcam, #ab75234, dilution 1:1000); monoclonal anti-b-Catenin antibody (BD Biosciences, #610154, dilution 1:1000); monoclonal anti-phospho-NFkB p65 (Ser536), anti-NFkB p65 antibody [D14E12] , and anti-NFAT [D43B1] (Cell Signaling, #3036, #8242, and 35861, respectively, dilution 1:1000); and anti-LRP5 (Abcam, #51910, dilution 1:500), followed by rabbit anti-mouse-HPR (1:10000), rabbit anti-goat-HPR (1:10000), or goat anti-rabbit-HPR (1:10000), according to convenience. Then, the membranes were stripped and blocked again with the same procedure, treated with a monoclonal or polyclonal anti-b-actin antibody (Abcam, #ab8226 or #ab8227, 0.2 mg/ml), followed by rabbit anti-mouse-HRP (1:10000) or goat anti-rabbit-HRP (1:10000), depending on the requirements. Membranes were washed to remove excess of antibodies and blots were developed by ECL systems (Amersham Biosciences). Band densities were analyzed with the ChemiDoc XRS TM system (Bio Rad) in chemiluminescence detection modus and with Quantity-One software (Bio Rad).
Pulse labeling and immunoprecipitation assays
20 × 10 6 PBMC were seeded in 100 mm-dishes with RPMI 1640 medium, 10% human serum A/B, 2 mM L-glutamine, 100 U/ml of penicillin G and 100 mg/ml of streptomycin, and 1% HEPES. After 24 h culturing at 378C, 5% CO 2 , non-adherent cells were removed by several washes in Ca 2+ and Mg 2+ -free PBS, and adherent cells were incubated with 5 ml of Methionine-free RPMI medium supplemented with 10% dialyzed human serum A/B for 30 min before labeling with 0.65 mCi of S 35 Methionine/Cysteine from E. coli hydrolysate (NEG 772, Perkin Elmer). After 16 h labeling, supernatants were collected, centrifuged 5 min at 100 g to eliminate cell debris, and added to HMEC-1 cultures for 4 h. Cells (monocytes and HMEC-1) were lysed with RIPA buffer (20 mM Tris at pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM Na 3 VO 4 with complete protease inhibitors (Roche)) and the resulting extracts were spun at 14000× g for 10 min at 48C. Samples were incubated with mouse anti-Wnt5a antibody (Abcam, #ab8720) at dilution 1:200 overnight. Afterwards, 20 ml of Protein G-Sepharose was added and incubated at 48C for 3 h and then washed with RIPA buffer for five times. IP samples were resuspended with 20 ml 3× SDS sample buffer with b-mercaptoethanol and load on SDS -PAGE gel. Labeled monocyte supernatants were also loaded in gels after being concentrated by using Amicon Ultra-4 centrifugal filter 3K device (Millipore). Gels were fixed with 10% acetic acid and 20% methanol, vacuum-dried at 508C for 2 h and visualized by Typhoon FLA9500 Phosphorimager (GE Healthcare Life Sciences).
Wnt5a transient transfection
PBMC were isolated as previously described. The insertion of plasmids into monocytes was done with a Nucleofector device and its kit V (Amaxa, Inc.). Transfection protocols were performed following the manufacturer's instructions using the X01 program. Either 0.4 mg of DNA from empty vector (pcDNA3.2) or active Wnt5a-V5 (from Adggene) was transfected to 1 × 10 7 cells. Then, monocytes were seeded as usual in order to obtain their conditioned medium.
